Nonfusion spinal surgery is all about preserving mobility and allowing the vertebrae to keep a more natural motion. This market is expected to keep growing at a 10% CAGR with the help of several factors, according to GBI Research:

• Good clinical trial results.
• Favorable reimbursement.
• Increased awareness about procedures.
• Higher income among patient populations in emerging economies.
• Technology developments.

Within the overall global spinal surgery market (fusion and nonfusion), Medtronic leads the pack with 34% market share. Other players in the field include DePuy (13%), Synthes (12%), and NuVasive.